Future studies should prioritize contingent self-administration protocols, longitudinal behavioral assessments, and tauopathy-resilient vs. susceptible animal strains, coupled with region-specific quantification of Tau isoforms and aggregates. This evidence concerns the gene MAPT and tauopathy.